Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks
- PMID: 2249197
- DOI: 10.1002/1097-0142(19901215)66:12<2569::aid-cncr2820661220>3.0.co;2-i
Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks
Abstract
This investigation examined the correlation between Helicobacter pylori (HP) infection, as reflected in immunoglobulin G serum antibodies, and the risk of gastric cancer. Serum samples were obtained from populations with contrasting gastric cancer risks. The highest prevalence of HP infection, 93%, was observed in the adult population at highest gastric cancer risk, the residents of Pasto, Colombia. In the lower risk Colombian city of Cali, a 63% overall prevalence rate was found. Both children and adults were sampled in New Orleans, Louisiana, where gastric cancer rates are high for blacks but not for whites. The prevalence of HP infection was significantly higher in black than in white adults, 70% versus 43%, P = 0.0001. A higher prevalence was also detected in black compared with white children, 49% versus 32%, P = 0.01; however, an even greater disparity was noted when comparing children from two hospitals, regardless of race, which serve different socioeconomic groups. A prevalence rate of 54% was found at Charity Hospital compared with 24% (P = 0.0001) at Children's Hospital. Our findings indicate that socioeconomic conditions, known to influence gastric cancer risk, are also important determinants of HP infection.
Similar articles
-
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.J Gastroenterol Hepatol. 1999 Feb;14(2):120-5. doi: 10.1046/j.1440-1746.1999.01823.x. J Gastroenterol Hepatol. 1999. PMID: 10029291
-
[Helicobacter pylori and the development of atrophic gastritis].Nihon Rinsho. 1993 Dec;51(12):3231-5. Nihon Rinsho. 1993. PMID: 8283639 Review. Japanese.
-
Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1410-7. doi: 10.1097/MEG.0b013e3283583ca5. Eur J Gastroenterol Hepatol. 2012. PMID: 23114744
-
Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.Eur J Gastroenterol Hepatol. 1996 Jul;8(7):645-9. Eur J Gastroenterol Hepatol. 1996. PMID: 8853252
-
[Helicobacter pylori and gastric adenocarcinoma: definitely related?].Gastroenterol Hepatol. 1998 Jan;21 Suppl 1:35-9. Gastroenterol Hepatol. 1998. PMID: 9549201 Review. Spanish. No abstract available.
Cited by
-
Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style.Dig Dis Sci. 2000 Jul;45(7):1322-9. doi: 10.1023/a:1005547802121. Dig Dis Sci. 2000. PMID: 10961710
-
Helicobacter anseris sp. nov. and Helicobacter brantae sp. nov., isolated from feces of resident Canada geese in the greater Boston area.Appl Environ Microbiol. 2006 Jul;72(7):4633-7. doi: 10.1128/AEM.02876-05. Appl Environ Microbiol. 2006. PMID: 16820454 Free PMC article.
-
The Use of Bacteria in Cancer Treatment: A Review from the Perspective of Cellular Microbiology.Emerg Med Int. 2022 Aug 8;2022:8127137. doi: 10.1155/2022/8127137. eCollection 2022. Emerg Med Int. 2022. PMID: 35978704 Free PMC article. Review.
-
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management.Front Oncol. 2019 Feb 22;9:75. doi: 10.3389/fonc.2019.00075. eCollection 2019. Front Oncol. 2019. PMID: 30854333 Free PMC article. Review.
-
Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis.Onco Targets Ther. 2020 Apr 2;13:2795-2805. doi: 10.2147/OTT.S239965. eCollection 2020. Onco Targets Ther. 2020. PMID: 32308414 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous